Committed to sharing our science

Committed to sharing our science

391 results available

Standard of Care Medication Patterns of Use Before and After Septal Myectomy in Patients with Obstructive Hypertrophic Cardiomyopathy

Poster, American College of Cardiology 2024 (ACC.24)

Post T, et al.

Atlanta, GA

April 5, 2024
Racial and Ethnic Differences in Cardiovascular Outcomes in Patients Diagnosed with Hypertrophic Cardiomyopathy

Poster, American College of Cardiology 2024 (ACC.24)

Reza N, et al.

Atlanta, GA

April 5, 2024
Efficacy and Safety of Aficamten in the First Cohort of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Completing 48-Week Follow-up: Findings From FOREST-HCM

Poster, American College of Cardiology 2024 (ACC.24)

Saberi S, et al.

Atlanta, GA

April 5, 2024
Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Aficamten and its Metabolites

Poster, American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2024

Xu D, et al

Colorado Springs, CO

March 28, 2024
Drug–Drug Interaction Study to Evaluate the Effect of Strong CYP3A Inhibition and P450 Induction on the Pharmacokinetics of Aficamten and the Effect of Aficamten on P-Glycoprotein in Healthy Participants

Poster, American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2024

Xu D, et al

Colorado Springs, CO

March 28, 2024